A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation-Reference-Cited by-同舟云学术

A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation

Published:2022-09-23 Issue:4 Volume:12 Page:4270-4281
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Metts Jonathan L.¹^ORCID,Trucco Matteo²,Weiser Daniel A.³^ORCID,Thompson Patrick⁴,Sandler Eric⁵,Smith Tiffany⁶,Crimella Jessica⁷,Sansil Samer⁸^ORCID,Thapa Ram⁹,Fridley Brooke L.⁹,Llosa Nicholas¹⁰,Badgett Thomas¹¹,Gorlick Richard¹²,Reed Damon¹³^ORCID,Gill Jonathan¹²

Affiliation:

1. Cancer and Blood Disorders Institute Johns Hopkins All Children's Hospital St Petersburg Florida USA

2. Cleveland Clinic Children's Hospital Department of Pediatric Hematology‐Oncology & Bone Marrow Transplantation Cleveland Ohio USA

3. Departments of Pediatrics and Genetics, Montefiore Medical Center Albert Einstein College of Medicine Bronx New York USA

4. Division of Pediatric Hematology‐Oncology University of North Carolina Health Care Chapel Hill North Carolina USA

5. Department of Pediatric Oncology Nemours Health Systems Jacksonville Florida USA

6. Cognitive Research Corporation St Petersburg Florida USA

7. Clinical Trials Office Partnerships H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

8. Cancer Pharmacokinetics and Pharmacodynamic Core H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

9. Department of Biostatistics and Bioinformatics H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

10. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine Baltimore Maryland USA

11. Department of Pediatrics University of Kentucky College of Medicine Lexington Kentucky USA

12. Department of Pediatrics University of Texas MD Anderson Cancer Center Houston Texas USA

13. Adolescent and Young Adult Program, Department of Interdisciplinary Cancer Management H. Lee Moffitt Cancer Center Tampa Florida USA

Funder

Rally Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5297

Reference35 articles.

1. Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

2. Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors

3. Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium Study

4. Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity;Pharmaceuticals;2024-06-05

2. What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?;Current Treatment Options in Oncology;2024-05-16

3. Antioxidant Activity and Antitumor Potential of Hedyotis chrysotricha Extract in Human Colorectal Cancer and Breast Cancer Cell Lines;The Natural Products Journal;2024-05

4. Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study);Discover Oncology;2023-06-06

5. Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors;Neuro-Oncology Advances;2023-01-01